Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soybean oil emulsion is a sterile intravenous lipid formulation used as a source of calories and essential fatty acids in patients requiring parenteral nutrition. It consists primarily of refined soybean oil—a mixture of triglycerides rich in polyunsaturated (mainly linoleic acid) and monounsaturated (mainly oleic acid) fatty acids—emulsified with egg phospholipids and stabilized with glycerin. The mechanism of action is to provide essential fatty acids and energy for metabolic processes when oral or enteral nutrition is not possible or insufficient. Soybean oil emulsions are the only FDA-approved lipid formulations for clinical use in parenteral nutrition[1][2][3][4][5][8]. Major brand names include Nutrilipid, Intralipid, and Clinolipid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on soybean oil emulsion.